![Expert Q&A: Adapting to the Expanding Market of At-Home Testing](https://www.g2intelligence.com/wp-content/uploads/2024/01/Feb24.CDI_.ExpertQA.WilliamGFinn.BK-iStock-1384699746-1100x800-1-1080x675.jpg)
Expert Q&A: Adapting to the Expanding Market of At-Home Testing
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
Understanding the 2024 CLFS update—and the changes that are still to come.
What clinical validation really means—and why every member of the laboratory should understand it.
Audits can be helpful not just for compliance purposes, but for maximizing reimbursement and maintaining a healthy business.
Join us and our expert to review important components a sales manager should consider in helping their staff be prepared, professional, and productive.
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.